NAS
TNDM icon

Nykredit A/S’s Tandem Diabetes Care TNDM Stock Holding History

Nykredit A/S’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4K Buy
+825
New +$14.4K ﹤0.01% 1846

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nykredit A/S's TNDM Position: Q2 2026 in Review

Nykredit A/S opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 825 shares worth $12.4K. The stake represents ﹤0.01% of the portfolio and ranks #1846 among its holdings.

185 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Nykredit A/S held 825 shares of Tandem Diabetes Care worth $12.4K as of Q2 2026.
  • Tandem Diabetes Care was a new Nykredit A/S position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1846 holding.
  • 185 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.